Skip to content

SOLIGENIX, INC.: 10-Q filed 2026-08-07

What SOLIGENIX, INC. reported in its quarterly report filed 2026-08-07 (fiscal Q2 2026): 34 published measures, 98 facts as tagged in accession 0001104659-26-092681.

This filing

Form
10-Q (quarterly report)
Filed
2026-08-07
Fiscal period
fiscal Q2 2026
Accession
0001104659-26-092681 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SOLIGENIX, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2026-06-3010,499,470USD
At 2025-12-319,235,521USD
At 2025-06-305,760,647USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2026-06-303,853,913USD
At 2025-12-313,943,396USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2026-06-306,645,557USD
At 2026-03-313,089,905USD
At 2025-12-315,292,125USD
At 2025-06-301,828,951USD
At 2025-03-313,897,933USD
At 2024-12-314,118,071USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-1,987,354USD91
2026-01-01 to 2026-06-30-4,812,319USD181
2025-04-01 to 2025-06-30-2,701,976USD91
2025-01-01 to 2025-06-30-5,653,244USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-4,064,414USD181
2025-01-01 to 2025-06-30-4,588,835USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-01-01 to 2025-06-303,313USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2026-01-01 to 2026-06-305,939,402USD181
2025-01-01 to 2025-06-301,870,304USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-3,313USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2026-06-30-249,863,451USD
At 2025-12-31-245,051,132USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2026-04-01 to 2026-06-3015,951,949shares91
2026-01-01 to 2026-06-3013,146,916shares181
2025-04-01 to 2025-06-303,278,677shares91
2025-01-01 to 2025-06-303,164,784shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2026-04-01 to 2026-06-3015,951,949shares91
2026-01-01 to 2026-06-3013,146,916shares181
2025-04-01 to 2025-06-303,278,677shares91
2025-01-01 to 2025-06-303,164,784shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-0.12USD/shares91
2026-01-01 to 2026-06-30-0.37USD/shares181
2025-04-01 to 2025-06-30-0.82USD/shares91
2025-01-01 to 2025-06-30-1.79USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-0.12USD/shares91
2026-01-01 to 2026-06-30-0.37USD/shares181
2025-04-01 to 2025-06-30-0.82USD/shares91
2025-01-01 to 2025-06-30-1.79USD/shares181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2026-06-306,577USD
At 2025-12-318,772USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2026-01-01 to 2026-06-30237,180USD181
2025-01-01 to 2025-06-30163,112USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-2,099,463USD91
2026-01-01 to 2026-06-30-4,984,301USD181
2025-04-01 to 2025-06-30-2,763,879USD91
2025-01-01 to 2025-06-30-5,790,387USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2026-06-3010,171,786USD
At 2025-12-318,849,007USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2026-06-303,671,839USD
At 2025-12-313,699,275USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2026-06-301,407,298USD
At 2025-12-311,115,497USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2026-04-01 to 2026-06-302,099,463USD91
2026-01-01 to 2026-06-304,984,301USD181
2025-04-01 to 2025-06-302,763,879USD91
2025-01-01 to 2025-06-305,790,387USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2026-04-01 to 2026-06-30974,091USD91
2026-01-01 to 2026-06-302,756,391USD181
2025-04-01 to 2025-06-301,677,014USD91
2025-01-01 to 2025-06-303,618,694USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2026-06-3021,637,479shares
At 2025-12-3110,086,130shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2026-06-309,811,141USD
At 2025-12-317,936,153USD
At 2025-06-305,097,670USD
At 2024-12-317,819,514USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2026-06-30256,441,582USD
At 2025-12-31250,287,382USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2026-06-3045,789USD
At 2025-12-3145,789USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2026-06-30298,330USD
At 2025-12-31354,965USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2026-06-302,059,974USD
At 2025-12-311,981,630USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-1,987,354USD91
2026-01-01 to 2026-06-30-4,812,319USD181
2025-04-01 to 2025-06-30-2,701,976USD91
2025-01-01 to 2025-06-30-5,653,244USD181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-4,812,319USD181
2025-01-01 to 2025-06-30-5,653,244USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-1,987,354USD91
2026-01-01 to 2026-06-30-4,812,319USD181
2025-04-01 to 2025-06-30-2,701,976USD91
2025-01-01 to 2025-06-30-5,653,244USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2026-04-01 to 2026-06-301,125,372USD91
2026-01-01 to 2026-06-302,227,910USD181
2025-04-01 to 2025-06-301,086,865USD91
2025-01-01 to 2025-06-302,171,693USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2026-04-01 to 2026-06-3058,511USD91
2026-01-01 to 2026-06-3056,995USD181
2025-04-01 to 2025-06-30-7,920USD91
2025-01-01 to 2025-06-30-8,708USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2026-04-01 to 2026-06-30112,109USD91
2026-01-01 to 2026-06-30171,982USD181
2025-04-01 to 2025-06-3061,903USD91
2025-01-01 to 2025-06-30137,143USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-06-3035,044USD181

Inspect the source

Entity
SOLIGENIX, INC. / CIK 0000812796
Captured
2026-09-19T15:06:29.331Z
SEC response SHA-256
8629fd5cf775c1125cd5ba8089602df0d09016eba95e768aec70a78328c796d0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000812796.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))